Pioneer Drug For Parkinson's Psychosis Wins FDA Approval
The U.S. Food and Drug Administration on Friday approved an innovative drug by Acadia Pharmaceuticals Inc. as the first and only medication to treat hallucinations and delusions stemming from Parkinson's disease...To view the full article, register now.
Already a subscriber? Click here to view full article